Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Directors' Subscription

29 Nov 2024 09:57

RNS Number : 1987O
CAP-XX Limited
29 November 2024
 

29 November 2024

CAP-XX Limited

("CAP-XX" or "the Company")

Directors' Subscription

Total voting rights

CAP-XX Limited (AIM:CPX), a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, announces an update on the subscription for new ordinary shares in the Company by certain directors of the Company (the "Directors' Subscription"), details of which were set out in the announcement of the Company's recent fundraise on 31 October 2024 (the "Launch Announcement").

Following the publication of the annual report and accounts for the financial year ended 30 June 2024, Dr Graham Cooley and Peter Fraser (the "Participating Directors") have conditionally subscribed for a total of approximately £0.25m (before expenses) of new Ordinary Shares pursuant to the Directors' Subscription. The Directors' Subscription will result in the issue and allotment of a total of 227,272,700 new Ordinary Shares (the "Subscription Shares") and is being carried out at the same issue price of 0.11 pence and substantially identical terms as those of the Placing. Details of the number of Subscription Shares being subscribed for and the resultant holdings of the Participating Directors are set out below.

Director

Current holding of Ordinary Shares

Number ofSubscription Shares being subscribed for

Resultant holding of Ordinary Shares

Percentage of enlarged share capital* (%)

Dr Graham Cooley

355,000,000

218,181,800

573,181,800

9.98%

Peter Fraser

-

9,090,900

9,090,900

0.16%

Total

355,000,000

227,272,700

582,272,700

 

* the current issued share capital of 3,357,210,402 Ordinary Shares as enlarged by the 1,908,743,235 Second Placing Shares, the Subscription Shares and the 250,000,000 Retail Offer Shares.

The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation, is appended further below.

Related Party Transaction

Dr Graham Cooley is a substantial shareholder and director of the Company and Peter Fraser is a director of the Company. Therefore the Participating Directors are deemed to be related parties pursuant to the AIM Rules for Companies (the "AIM Rules").

The Directors' Subscription constitutes a related party transaction in accordance with Rule 13 of the AIM Rules. Accordingly, the independent Directors (being Patrick Elliot, Steen Feldskov, Dr Anthony Sive and Lars Stegmann) consider, having consulted with the Company's Nominated Adviser, Allenby Capital Limited, that the terms of the Directors' Subscription are fair and reasonable insofar as the Company's shareholders are concerned.

Application for admission to trading on AIM and total voting rights

Application has been made for the Subscription Shares to be admitted to trading on AIM and it is anticipated that this will take place at 8.00 a.m. on or around 9 December 2024, at the same time as the admission of the Second Placing Shares and the Retail Offer Shares ("Second Admission").

Following admission of the Subscription Shares and Second Admission, the Company's issued ordinary share capital will comprise 5,743,226,337 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Accordingly, the above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined, definitions contained in this announcement have the same meaning as set out in the Launch Announcement.

For further information contact:

CAP-XX Limited

Pat Elliott (Chairman) +61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Piers Shimwell (Corporate Finance)  +44 (0) 20 3328 5656

Jos Pinnington/Tony Quirke (Sales and Corporate Broking)

 

Notes to Editors:

About CAP-XX

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1) Dr Graham Cooley

2) Peter Fraser

2.

Reason for the Notification

a)

Position/status

1) Non-Executive Director

2) Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CAP-XX Limited

b)

LEI

213800HECUSIYXH3WN26

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of no par value each

Identification code

ISIN: AU0000XINAS1

b)

Nature of the transaction

Subscription for Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1) 0.11 pence per share

218,181,800

2) 0.11 pence per share

9,090,900

d)

Aggregated information:

-Aggregated volume

-Price

n/a

e)

Date of the transaction

29 November 2024 to be completed on 9 December 2024

f)

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKZMZMLLVGDZG
Date   Source Headline
3rd Nov 20227:00 amRNSChairman’s AGM Statement
19th Oct 20227:00 amRNSNotice of AGM
13th Oct 20227:00 amRNSHolding(s) in Company
29th Sep 20227:00 amRNSAudited results for the year ended 30 June 2022
29th Jul 20225:00 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSAgreement with Systematic Power Manufacturing LLC
12th Jul 20227:00 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jul 20227:00 amRNSPre-close trading update
28th Jun 20227:00 amRNSCAP-XX Adds Lithium-ion Capacitors to Portfolio
26th May 20227:00 amRNSCAP-XX collaboration with UNSW
4th May 20224:41 pmRNSSecond Price Monitoring Extn
4th May 20224:36 pmRNSPrice Monitoring Extension
4th May 20222:06 pmRNSSecond Price Monitoring Extn
4th May 20222:00 pmRNSPrice Monitoring Extension
4th May 20227:00 amRNSCAP-XX secures joint venture with Ionic Industries
12th Apr 20227:00 amRNSAppointment of Director and Grant of Share Options
28th Feb 20227:00 amRNSNotice of Investor Presentation
23rd Feb 20227:00 amRNSInterim Results
23rd Feb 20227:00 amRNSCAP-XX Secures Continental Automotive as Customer
8th Feb 20227:01 amRNSMCCI contract win
8th Feb 20227:00 amRNSCenkos Growth & Innovation Forum presentation
7th Feb 20229:00 amRNSNotification of date of interim results
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSXtel Wireless Selects CAP-XX Supercapacitors
10th Dec 20217:00 amRNSFiiO Selects CAP-XX Supercaps
6th Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSIssue of Shares and Director/PDMR Shareholdings
3rd Nov 20217:00 amRNSR&D Tax Rebate
27th Oct 20219:35 amRNSResult of AGM and Chairman’s AGM statement
14th Oct 20219:56 amRNSGrant of Share Options
5th Oct 20217:00 amRNSNotice of AGM
29th Sep 20217:00 amRNSAudited results for the year ended 30 June 2021
28th Sep 20217:00 amRNSCAP-XX Appoints Kessler Batteries as Distributor
14th Sep 20217:00 amRNSNotice of Results
7th Sep 20217:00 amRNSSpire Health Selects CAP-XX Supercapacitors
31st Aug 20215:00 pmRNSTotal Voting Rights
12th Aug 20217:00 amRNSHolding(s) in Company
11th Aug 20217:00 amRNSHolding(s) in Company
4th Aug 20217:00 amRNSResult of Placing and Completed Sale of Shares
3rd Aug 20213:33 pmRNSProposed Placing and Proposed Sale of Sale Shares
21st Jul 20217:00 amRNSRGM SpA Selects CAP-XX 3000F Supercapacitors
30th Jun 20215:00 pmRNSTotal Voting Rights
16th Jun 20217:00 amRNSSensys Networks Selects CAP-XX Supercapacitors
10th Jun 20217:00 amRNSPre-close trading update
1st Jun 20217:00 amRNSEveractive Selects CAP-XX for IoT Systems
17th May 202110:12 amRNSNotification of transactions by PDMRs
4th May 20217:00 amRNSCAP-XX Supercapacitors Selected by Jack
30th Apr 20211:03 pmRNSNotification of transactions by PDMRs
26th Apr 20217:00 amRNSVAIMOO Selects CAP-XX Supercapacitors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.